Everolimus 10mg Tablet

Everolimus 10mg Tablet is a prescription targeted anticancer product that belongs to the mTOR inhibitor class. It is widely used in the treatment of advanced breast cancer, renal cell carcinoma, and neuroendocrine tumors. This oral therapy helps manage tumor growth by blocking key pathways that support cancer cell proliferation and angiogenesis.

The active ingredient, everolimus, works by inhibiting the mTOR signaling pathway, which is crucial for cancer cell survival and blood vessel formation. By targeting these mechanisms, everolimus slows disease progression and enhances the effectiveness of combination cancer therapies under strict oncologist supervision.

Everolimus 10 mg Tablet is administered orally and is a prescription-only product used according to established oncology protocols. This ensures consistent therapeutic effectiveness, patient safety, and long-term disease management for patients with advanced cancers.

Product Features

• Targeted anticancer therapy tablet
• Contains Everolimus 10 mg
• mTOR pathway inhibitor
• Used in breast cancer, kidney cancer & NETs
• Oral tablet dosage form
• Suitable for long-term targeted therapy
• Manufactured under strict pharmaceutical quality standards
• Prescription-required oncology medicine

How It Helps

• Blocks mTOR pathways to slow cancer cell growth
• Helps manage advanced breast cancer, kidney cancer, and NETs
• Inhibits angiogenesis to restrict tumor blood supply
• Supports long-term targeted therapy under oncologist supervision